论文部分内容阅读
脑血管病的高发病率,高致残率是严重威胁人类生存及生存质量的疾病。目前对缺血性脑血管病的治疗及减少复发问题一直困扰着神经科学界的工作者。脑血管病危险因素的干预(除药物外),尤其是颈内动脉支架成形术(carotid artery stenting,CAS)成为神经科学界关注的问题。颈动脉内膜切除术(carotid endarterectomy,CEA)作为治疗颈动脉狭窄的金标准并未被撼动,然而对于潜在的心脏疾病患者而
High incidence of cerebrovascular disease, high morbidity is a serious threat to human survival and quality of life of the disease. The current treatment of ischemic cerebrovascular disease and reduce the recurrence has been plagued neurological workers. Interventions for cardiovascular risk factors (other than drugs), especially carotid artery stenting (CAS), have been of major concern to the neuroscience community. Carotid endarterectomy (CEA) as the gold standard for the treatment of carotid artery stenosis has not been shaken, however, for patients with underlying heart disease